PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BDSX vs. CRNC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BDSX and CRNC is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

BDSX vs. CRNC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%500.00%600.00%AugustSeptemberOctoberNovemberDecember2025
-8.06%
545.76%
BDSX
CRNC

Key characteristics

Sharpe Ratio

BDSX:

-0.41

CRNC:

-0.00

Sortino Ratio

BDSX:

-0.22

CRNC:

1.96

Omega Ratio

BDSX:

0.97

CRNC:

1.23

Calmar Ratio

BDSX:

-0.25

CRNC:

-0.01

Martin Ratio

BDSX:

-0.88

CRNC:

-0.01

Ulcer Index

BDSX:

27.54%

CRNC:

68.69%

Daily Std Dev

BDSX:

59.19%

CRNC:

207.12%

Max Drawdown

BDSX:

-96.88%

CRNC:

-98.22%

Current Drawdown

BDSX:

-95.23%

CRNC:

-85.78%

Fundamentals

Market Cap

BDSX:

$222.56M

CRNC:

$337.46M

EPS

BDSX:

-$0.37

CRNC:

-$14.12

Total Revenue (TTM)

BDSX:

$50.89M

CRNC:

$193.17M

Gross Profit (TTM)

BDSX:

$39.66M

CRNC:

$131.72M

EBITDA (TTM)

BDSX:

-$24.12M

CRNC:

-$625.55M

Returns By Period

In the year-to-date period, BDSX achieves a -2.61% return, which is significantly lower than CRNC's 141.66% return.


BDSX

YTD

-2.61%

1M

10.37%

6M

-8.02%

1Y

-23.59%

5Y*

N/A

10Y*

N/A

CRNC

YTD

141.66%

1M

128.28%

6M

547.44%

1Y

-4.72%

5Y*

-1.60%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BDSX vs. CRNC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BDSX
The Risk-Adjusted Performance Rank of BDSX is 2828
Overall Rank
The Sharpe Ratio Rank of BDSX is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of BDSX is 2727
Sortino Ratio Rank
The Omega Ratio Rank of BDSX is 2727
Omega Ratio Rank
The Calmar Ratio Rank of BDSX is 3232
Calmar Ratio Rank
The Martin Ratio Rank of BDSX is 2727
Martin Ratio Rank

CRNC
The Risk-Adjusted Performance Rank of CRNC is 5959
Overall Rank
The Sharpe Ratio Rank of CRNC is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of CRNC is 8080
Sortino Ratio Rank
The Omega Ratio Rank of CRNC is 7676
Omega Ratio Rank
The Calmar Ratio Rank of CRNC is 4747
Calmar Ratio Rank
The Martin Ratio Rank of CRNC is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BDSX vs. CRNC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BDSX, currently valued at -0.41, compared to the broader market-4.00-2.000.002.00-0.41-0.00
The chart of Sortino ratio for BDSX, currently valued at -0.22, compared to the broader market-4.00-2.000.002.004.00-0.221.96
The chart of Omega ratio for BDSX, currently valued at 0.97, compared to the broader market0.501.001.502.000.971.23
The chart of Calmar ratio for BDSX, currently valued at -0.25, compared to the broader market0.002.004.006.00-0.25-0.01
The chart of Martin ratio for BDSX, currently valued at -0.88, compared to the broader market-10.000.0010.0020.00-0.88-0.01
BDSX
CRNC

The current BDSX Sharpe Ratio is -0.41, which is lower than the CRNC Sharpe Ratio of -0.00. The chart below compares the historical Sharpe Ratios of BDSX and CRNC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.41
-0.00
BDSX
CRNC

Dividends

BDSX vs. CRNC - Dividend Comparison

Neither BDSX nor CRNC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BDSX vs. CRNC - Drawdown Comparison

The maximum BDSX drawdown since its inception was -96.88%, roughly equal to the maximum CRNC drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for BDSX and CRNC. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%AugustSeptemberOctoberNovemberDecember2025
-95.23%
-85.78%
BDSX
CRNC

Volatility

BDSX vs. CRNC - Volatility Comparison

The current volatility for Biodesix, Inc. (BDSX) is 19.14%, while Cerence Inc. (CRNC) has a volatility of 93.40%. This indicates that BDSX experiences smaller price fluctuations and is considered to be less risky than CRNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
19.14%
93.40%
BDSX
CRNC

Financials

BDSX vs. CRNC - Financials Comparison

This section allows you to compare key financial metrics between Biodesix, Inc. and Cerence Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab